Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor.
about
Molecular cloning and characterization of GalNAc 4-sulfotransferase expressed in human pituitary glandMolecular characterization and expression of heparan-sulfate 6-sulfotransferase. Complete cDNA cloning in human and partial cloning in Chinese hamster ovary cellsBiosynthesis of heparan sulphate with diverse structures and functions: two alternatively spliced forms of human heparan sulphate 6-O-sulphotransferase-2 having different expression patterns and propertiesHeparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factorCrystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor.The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanasesReceptors for fibroblast growth factorsCombined strong anion-exchange HPLC and PAGE approach for the purification of heparan sulphate oligosaccharidesThe occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamineStimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypicanFell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra.Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding.Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney.Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometryHighly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractionsExpression of basic fibroblast growth factor in intact and ulcerated human gastric mucosa.2-O Heparan Sulfate Sulfation by Hs2st Is Required for Erk/Mapk Signalling Activation at the Mid-Gestational Mouse Telencephalic Midline.Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF.Heparan sulfates in skeletal muscle development and physiology.A single protein catalyzes both N-deacetylation and N-sulfation during the biosynthesis of heparan sulfate.Adherence of pilus- Opa+ gonococci to epithelial cells in vitro involves heparan sulfateExpression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum.Molecular cloning and expression of Chinese hamster ovary cell heparan-sulfate 2-sulfotransferase.NMR solution conformation of heparin-derived hexasaccharide.Diaphragm adaptations in patients with COPD.Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans.Functions of chondroitin sulfate and heparan sulfate in the developing brain.Heparan sulfate in angiogenesis: a target for therapy.Sugar glues for broken neuronsCharacterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor.The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate.6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture.Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factorMolecular characterization of Xenopus embryo heparan sulfate. Differential structural requirements for the specific binding to basic fibroblast growth factor and follistatin.Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain.An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation.Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entrySyndecan family of cell surface proteoglycans: developmentally regulated receptors for extracellular effector molecules.Monomer complexes of basic fibroblast growth factor and heparan sulfate oligosaccharides are the minimal functional unit for cell activation.
P2860
Q24290298-A9A1374C-BB54-4C2B-8B3E-802CF06E4B6EQ24322572-8E4D8DA8-14DF-49D7-B635-B9A65A86F48FQ24535653-586F4875-6E1E-4470-9E79-720061A546F0Q24561731-42FAF545-CF04-499A-A492-C79B7455473BQ24651739-76AC245A-12EF-4069-A800-7F8E8944039DQ27635335-1CC12D25-C202-4F65-A9A5-965F27014D3FQ28278296-066E9984-DB5B-4686-A7B7-48C16657EA2AQ28285082-9E787476-2B5E-4A0E-93FD-29D20031955AQ28348093-47779B7E-9B6E-4548-937E-83078B0828A9Q28594700-4479A0E3-FCB9-48ED-BDE4-17B05671B7FCQ28633960-D328E6D5-5837-4244-B410-7204C49C95CAQ30568524-84D883A2-7173-4777-94B6-CE9F07F5C0D9Q31074211-5B1EB806-90F7-4934-B3BD-755D8D46C9B9Q32064386-C117F4A4-0173-49A8-9CC9-887C3A758F94Q33546538-55FD0BD5-04A9-41E2-B5E4-B1D5B311D2B7Q33864454-67E5A312-BED0-4012-A51A-8DB1258337BAQ35352420-091EB418-C431-4D0B-8921-E6B486F193D8Q35663605-E59B0B9B-D8C3-4A30-BFA4-33BACD293018Q35965194-802F85B4-1071-44A3-8DB1-E0F0243D6D16Q36180874-424AC3B7-190B-4EA5-8A0A-0F26D5CF2CF1Q36269188-DA03B8F3-C061-4FCF-8C34-167BA4E73D80Q36365234-DBC6411D-13B5-46A4-B855-540070FDD86EQ36797422-34504969-7473-4A1F-92A7-91CE3D36D943Q36861170-B91815CF-C43C-4093-96AB-23B4FF7A853AQ36889781-D29CFCCD-3FB5-4C88-B788-2BB61A0405C3Q37064535-DD4F44AE-7550-4E28-B614-9769EA5A1B9FQ37560675-559CC4F5-FB00-469C-B996-FD1D21358C0BQ37812566-CAD274C7-BEB2-4132-AAD6-7795A3018ADBQ38154506-A017BD8A-17E1-4CE1-88BF-0A8C1C955BDFQ38256971-B30461D3-45CB-4EAC-9A95-0ED202995592Q38288128-5B434D35-AA99-414B-B67D-EB8F774DA6C4Q38290246-A17EF75F-2902-40FE-B5DD-DCCD02098537Q38293479-2BAA087C-1E35-4360-8643-53F832D99F22Q38303388-77A661EC-1A63-447C-8941-5637C6FA48E5Q38338351-4D1BDEE8-36EA-4A52-A845-F02CC86E6939Q38348282-15B462D7-7666-4E2A-A425-26754F123997Q38355072-A08A53C3-9983-4FE6-A01D-FE2115E9C1DAQ39874536-E40A7670-874C-422E-9A7B-5582CE81409CQ40412665-D2A1AC96-48D8-4790-A81B-BA64F484350CQ40957417-0270694C-CB79-44E4-95B8-0F98BF8C5982
P2860
Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Structure of a heparan sulphat ...... asic fibroblast growth factor.
@en
type
label
Structure of a heparan sulphat ...... asic fibroblast growth factor.
@en
prefLabel
Structure of a heparan sulphat ...... asic fibroblast growth factor.
@en
P2093
P2860
P356
P1433
P1476
Structure of a heparan sulphat ...... asic fibroblast growth factor.
@en
P2093
P2860
P304
P356
10.1042/BJ2850805
P407
P478
285 ( Pt 3)
P577
1992-08-01T00:00:00Z